GREEN after consultant/specialist initiation: for epilepsy
GREEN: 3rd line for neuropathic pain (Decision date - April 2023). See guideline for managing neuropathic pain in primary care
DO NOT PRESCRIBE (DNP): Neurontin brand is BLACK for non-epilepsy conditions. (Decision date - August 2019)